Author:
Parisey M.,Houze S.,Bailly J.,Taudon N.,Jaffal K.,Argy N.,Rouzaud C.,Mégarbane B.,Lariven S.,Yazdanpanah Y.,Matheron S.
Reference22 articles.
1. MALACEF 60 mg, poudre et solvant pour solution injectable - ANSM: Agence nationale de sécurité du médicament et des produits de santé [Internet]. [cited 2020 Jan 7]. Available from: 〈https://www.ansm.sante.fr/Activites/Autorisations-temporaires-d-utilisation-ATU/Referentiel-des-ATU-nominatives/Referentiel-des-ATU-nominatives/MALACEF-60-mg-poudre-et-solvant-pour-solution-injectable〉.
2. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study;Spring;Lancet Infect Dis,2015
3. Antimalarial drug resistance in Africa: the calm before the storm?;Conrad;Lancet Infect Dis,2019
4. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study;Witkowski;Lancet Infect Dis,2018
5. K-13 propeller gene polymorphisms isolated between 2014 and 2017 from Cameroonian Plasmodium falciparum malaria patients;Eboumbou Moukoko;PloS One,2019